Novel phthalimides regulating PD-1/PD-L1 interaction as potential immunotherapy agents

Novel phthalimides regulating PD-1/PD-L1 interaction as potential immunotherapy agents

Programmed cell death 1(PD-1)/programmed cell death ligand 1(PD-L1) have emerged as one of the most promising immune checkpoint targets for cancer immunotherapy. Despite the inherent advantages of small-molecule inhibitors over antibodies, the discovery of small-molecule inhibitors has fallen behind...

詳細記述

書誌詳細
主要な著者: Chengliang Sun, Yao Cheng, Xiaojia Liu, Gefei Wang, Wenjian Min, Xiao Wang, Kai Yuan, Yi Hou, Jiaxing Li, Haolin Zhang, Haojie Dong, Liping Wang, Chenguang Lou, Yanze Sun, Xinmiao Yu, Hongbin Deng, Yibei Xiao, Peng Yang
フォーマット: 論文
言語:English
出版事項: Elsevier 2022-12-01
シリーズ:Acta Pharmaceutica Sinica B
主題:
PD-1/PD-L1
Small-molecule inhibitor
Immunotherapy
Co-crystal structure
オンライン･アクセス:http://www.sciencedirect.com/science/article/pii/S2211383522001770

インターネット

http://www.sciencedirect.com/science/article/pii/S2211383522001770

類似資料